Financhill
Sell
30

RDHL Quote, Financials, Valuation and Earnings

Last price:
$1.20
Seasonality move :
-10.63%
Day range:
$1.17 - $1.20
52-week range:
$1.01 - $7.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.00x
P/B ratio:
1.13x
Volume:
20.4K
Avg. volume:
86.4K
1-year change:
-81.76%
Market cap:
$3.9M
Revenue:
$8.1M
EPS (TTM):
--

Earnings Data

Next earnings date for RDHL
--
Most recent earnings per share
$4.75
Beat by $4.75
(Aug 17/2023)
Consensus Estimate
--
(Aug 17/2023)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RDHL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/17/2023 Q2 -- $1.8M $4.75 -- --
06/23/2023 Q1 -- $3.6M $510.97 -- --
03/17/2023 Q4 $18.1M $12.8M -$39.89 -- --
11/29/2022 Q3 $18.5M $17.4M -$554.81 -$10.00 -$544.81
09/27/2022 Q2 $21.5M $18.1M -$203.67 -$10.00 -$193.67
06/23/2022 Q1 $23.6M $13.1M -$390.45 -$30.00 -$360.45
03/17/2022 Q4 $24.1M $22.2M -$490.44 -$430.00 -$60.44
11/30/2021 Q3 $23.4M $21.7M -$459.24 -$0.25 -$458.99
08/26/2021 Q2 $24.3M $21.6M -$626.10 -$248.00 -$378.10
05/27/2021 Q1 $22.7M $20.4M -$526.69 -$278.00 -$248.69
03/18/2021 Q4 -- $21.6M -$638.83 -- --
11/12/2020 Q3 -- $21.1M -$503.63 -- --
08/13/2020 Q2 -- $21.1M -$452.89 -- --
05/27/2020 Q1 -- $1.1M -$487.34 -- --
03/04/2020 Q4 -- $1.6M -$332.52 -- --
11/19/2019 Q3 -- $1.4M -$349.09 -- --
07/23/2019 Q2 -- $1.6M -$384.07 -- --
05/07/2019 Q1 -- $1.7M -$349.28 -- --
02/26/2019 Q4 -- $1.3M -$269.06 -- --
11/13/2018 Q3 -- $2.2M -$428.77 -- --
08/30/2018 Q2 -- $2.3M -$516.64 -- --
03/31/2018 Q1 -- $2.4M -$465.57 -- --
02/22/2018 Q4 -- $2.1M -$514.22 -- --
11/13/2017 Q3 -- $1.6M -$928.82 -- --
07/25/2017 Q2 -- $508.6K -$631.75 -- --
04/19/2017 Q1 -- -- -$515.80 -- --
02/23/2017 Q4 -- $99.9K -$599.49 -- --
11/14/2016 Q3 -- -- -$712.55 -- --
07/26/2016 Q2 -- $1K -$607.83 -- --
04/20/2016 Q1 -- -- -$400.36 -- --
02/25/2016 Q4 -- -- -$501.31 -- --

RedHill Biopharma Ltd. Earnings Questions

  • How Much did RedHill Biopharma Ltd. Generate in Revenue Last Quarter?

    RedHill Biopharma Ltd. reported $1.8M worth of top line sales in its most recent quarter.

  • Did RedHill Biopharma Ltd. Beat Earnings Last Quarter?

    RedHill Biopharma Ltd. announced earnings per share of $4.75 which represents a beat of analyst forecast a -- per share.

  • Is RedHill Biopharma Ltd. Profitable?

    RedHill Biopharma Ltd. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for RedHill Biopharma Ltd. EPS Next Year?

    RedHill Biopharma Ltd.'s earnings are forecast to grow from -$6.73 per share to -- per share next year representing an increase of --.

  • When is RedHill Biopharma Ltd.'s Earnings Date?

    Currently, RedHill Biopharma Ltd. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 22, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 20

Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.

Buy
54
BMRN alert for Dec 20

BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.

Buy
82
RKLB alert for Dec 20

Rocket Lab Corp. [RKLB] is up 17.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock